Zoetis Inc. (ZTS) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026
Summary
Zoetis’s revenue went from $4.9B in fiscal 2016 to $9.5B in fiscal 2025, growth of about 7.6% a year.
Net income in fiscal 2025 was $2.7B, a net margin of 28.2%; the highest of the period.
Over the twelve months to September 30, 2026, revenue was $9.5B and net income $2.5B.
Free cash flow was $2.3B in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count fell 11% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.5B | $9.5B | $9.3B | $8.5B | $8.1B | $7.8B | $6.7B | $6.3B | $5.8B | $5.3B | $4.9B |
| Gross profit | $6.8B | $6.8B | $6.5B | $6.0B | $5.6B | $5.5B | $4.6B | $4.3B | $3.9B | $3.5B | $3.2B |
| Operating income | $3.4B | $3.6B | $3.4B | $3.2B | $2.9B | $2.7B | $2.2B | $2.0B | $1.9B | $1.7B | $1.4B |
| Net income | $2.5B | $2.7B | $2.5B | $2.3B | $2.1B | $2.0B | $1.6B | $1.5B | $1.4B | $864M | $821M |
| EPS (diluted) | $5.93 | $6.02 | $5.47 | $5.07 | $4.49 | $4.27 | $3.42 | $3.11 | $2.93 | $1.75 | $1.65 |
| R&D | $722M | $698M | $686M | $614M | $539M | $508M | $463M | $457M | $432M | $382M | $376M |
| Revenue growth | — | +2.3% | +8.3% | +5.7% | +3.9% | +16.5% | +6.6% | +7.5% | +9.8% | +8.6% | +2.6% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.7B | $2.9B | $3.0B | $2.4B | $1.9B | $2.2B | $2.1B | $1.8B | $1.8B | $1.3B | $713M |
| Capital spending | -$493M | -$621M | -$655M | -$732M | -$586M | -$477M | -$453M | -$460M | -$338M | -$224M | -$216M |
| Free cash flow | $2.2B | $2.3B | $2.3B | $1.6B | $1.3B | $1.7B | $1.7B | $1.3B | $1.5B | $1.1B | $497M |
| Dividends paid | $886M | $889M | $786M | $692M | $611M | $474M | $380M | $314M | $243M | $206M | $188M |
| Buybacks | $4.7B | $3.2B | $1.9B | $1.1B | $1.6B | $743M | $250M | $626M | $698M | $500M | $300M |
| Stock-based pay | $100M | $83M | $74M | $60M | $62M | $58M | $59M | $67M | $53M | $44M | $37M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $2.3B | $2.0B | $2.0B | $3.6B | $3.5B | $3.6B | $1.9B | $1.7B | $1.6B | $727M |
| Debt | — | $9.4B | $6.9B | $6.9B | $8.2B | $6.8B | $7.5B | $6.7B | $6.7B | $5.0B | $4.5B |
| Equity | — | $3.3B | $4.8B | $5.0B | $4.4B | $4.5B | $3.8B | $2.7B | $2.2B | $1.8B | $1.5B |
| Total assets | — | $15.5B | $14.2B | $14.3B | $14.9B | $13.9B | $13.6B | $11.5B | $10.8B | $8.6B | $7.6B |
| Shares (diluted) | 412M | 444M | 455M | 462M | 470M | 477M | 479M | 482M | 487M | 493M | 498M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 71.6% | 71.8% | 70.6% | 70.0% | 69.6% | 70.4% | 69.2% | 68.2% | 67.2% | 66.5% | 65.9% |
| Operating margin | 35.6% | 37.8% | 36.3% | 37.2% | 35.6% | 34.9% | 33.4% | 32.3% | 32.6% | 32.0% | 28.5% |
| Net margin | 26.4% | 28.2% | 26.9% | 27.4% | 26.2% | 26.2% | 24.5% | 24.0% | 24.5% | 16.3% | 16.8% |
| FCF margin | 23.5% | 24.1% | 24.8% | 19.0% | 16.4% | 22.3% | 25.1% | 21.3% | 24.9% | 21.1% | 10.2% |
| ROIC | — | 22.4% | 23.0% | 21.3% | 18.1% | 19.5% | 16.3% | 17.9% | 18.0% | 14.2% | 15.5% |
| ROE | — | 80.2% | 52.1% | 46.9% | 48.0% | 44.8% | 43.5% | 55.4% | 65.3% | 48.8% | 55.2% |
Frequently asked questions
What is Zoetis’s annual revenue?
$9.5B in fiscal 2025 and $9.5B over the twelve months to September 30, 2026.
How much profit does Zoetis make?
Net income was $2.7B in fiscal 2025 (net margin 28.2%).
Is Zoetis’s revenue growing?
Yes: revenue rose 2.3% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.